drugset / Trial / NCT00270829

Renal Effects of Intrarenal Nesiritide

NCT00270829

Phase 4 Terminated 2 enrolled University of Maryland, Baltimore
RandomizedParallel-groupOpen-labelTreatment

Summary

The impact of nesiritide in CHF is unclear, but it is possible that systemic vasodilation leads to adverse consequences even if the direct renal effects are positive. Therefore, this study will look at the effects of direct intrarenal administration of nesiritide on GFR and RPF.

Timeline

Start
2005-12
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nesiritide Protein / enzyme biologic 0.01 mg/kg Other